Dennis M Lanfear Coherus Bio Sciences, Inc. (CHRS) insider trading activity

Dennis M Lanfear is President & CEO of Coherus BioSciences, Inc.. Currently has a direct ownership of 685,074 shares of CHRS, which is worth approximately $897,446. The most recent transaction as insider was on Jan 20, 2025, when has been sold 11,810 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $16,415. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 685K

3.33% 3M change

3.33% 12M change

Total Value Held $897,446

Dennis M Lanfear Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 20 2025	SELL Payment of exercise price or tax liability	$16,415 $1.39 p/Share	11,810 Reduced 1.69%	685,074 Common Stock
Jan 04 2025	SELL Payment of exercise price or tax liability	$19,604 $1.66 p/Share	11,810 Reduced 1.67%	696,884 Common Stock
Jan 20 2024	SELL Payment of exercise price or tax liability	$27,371 $2.44 p/Share	11,218 Reduced 1.56%	708,694 Common Stock
Jan 04 2024	SELL Payment of exercise price or tax liability	$34,400 $2.92 p/Share	11,781 Reduced 1.61%	719,912 Common Stock
Nov 22 2023	SELL Open market or private sale	$450,662 $2.02 p/Share	223,100 Reduced 23.37%	731,693 Common Stock
Nov 22 2023	BUY Exercise of conversion of derivative security	$425,914 $1.42 p/Share	299,940 Added 23.9%	954,793 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	86,250 Added 11.64%	654,853 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$107,632 $9.87 p/Share	10,905 Reduced 1.88%	568,603 Common Stock
Jan 04 2022	BUY Grant, award, or other acquisition	-	86,250 Added 12.96%	579,508 Common Stock
Jun 08 2021	SELL Open market or private sale	$421,092 $13.56 p/Share	31,054 Reduced 5.92%	493,258 Common Stock
Jun 08 2021	BUY Exercise of conversion of derivative security	$13,043 $0.42 p/Share	31,054 Added 5.59%	524,312 Common Stock
Jun 06 2021	BUY Exercise of conversion of derivative security	$126,000 $0.42 p/Share	300,000 Added 37.82%	493,258 Common Stock

DML

Dennis M Lanfear

President & CEO

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Value

Insider Trading

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Coherus BioSciences, Inc.

Track Activities on CHRS

Account